AdvaMed® Statement on Today’s Violence at the U.S. Capitol
WASHINGTON, D.C. – On behalf of AdvaMed®, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – On behalf of AdvaMed®, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
Washington, D.C. — The Medtech Conference won several International Association of Exhibitions and Events (IAEE) Art of the Show Competition awards, including Best Email Promotion Campaign, Best Show Promotion Website, and tied for the prestigious…
The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Ecuador Trade Package announced today.
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry shows that total U.S. shipments of COVID-19 molecular diagnostic tests have topped more than 255 million since the beginning of…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
Washington, D.C – Today the Advanced Medical Technology Association® (AdvaMed®), under the leadership of the Board of Directors, issued a set of principles to guide the industry in addressing racial health disparities.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week joined medtech industry, government and other health care stakeholders at the Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized…
WASHINGTON, D.C. –New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
WASHINGTON, D.C. – New data from AdvaMed®’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from President and CEO Scott Whitaker on the newly concluded United States-Brazil Trade Package: